Accenture: Wedbush adjusts price target to $300 from $350; outperform rating kept.
AGCO: Baird initiated coverage with a recommendation of outperform. PT rises 65% to $156.
Biogen: BMO Capital Markets upgrades to outperform from market perform. PT jumps 82% to $360.
CVS Group: Jefferies…
© MarketScreener.com 2022